At 2.5% CAGR, Middle East & Africa Blood Gas and Electrolyte Analyzer Market is Projected to be Worth US$ 77.04 Million by 2031, says Business Market Insights

According to Business Market Insights’ research, the Middle East & Africa blood gas and electrolyte analyzer market was valued at US$ 63.39 million in 2023 and is expected to reach US$ 77.04 million by 2031, registering a CAGR of 2.5% from 2023 to 2031. Increasing number of patients in emergency units of hospitals and new product launches and approvals are among the critical factors attributed to drive the Middle East & Africa blood gas and electrolyte analyzer market growth.

The rising prevalence of diabetes, cancer, heart disease, and other chronic conditions propels the requirement for hospital emergency rooms (ER). Hospital emergency rooms offer vital medical care for patients affected by severe chronic conditions who need immediate attention and medical intervention. These services are complex, with each part being crucial to providing care. The primary objective of emergency medical services is immediately treating medical, surgical, and obstetric problems. The increasing number of patients seeking care in emergency hospital emergency units positively impacts the demand for blood gas and electrolyte analyzers. According to the World Health Organization (WHO), around 150 million patients visit hospital emergency rooms across the world annually. As emergency departments face mounting pressure to deliver rapid and accurate assessments of critically ill patients, timely diagnostic information on blood gas values, electrolyte levels, and acid-base balance becomes paramount. Blood gas and electrolyte analyzers provide on-the-spot diagnostic data for evaluating and managing patients affected by respiratory distress, metabolic abnormalities, or critical conditions. The ability of these analyzers to provide real-time insights into a patient's oxygenation status, acid-base equilibrium, and electrolyte levels is crucial for guiding resuscitative measures and optimizing clinical outcomes in emergency settings.

The growing demand for blood gas and electrolyte analyzers in emergency units drives advancements in technology, such as portable and point-of-care devices, that enable rapid testing at the patient's bedside. These compact analyzers enhance workflow efficiency and improve patient outcomes by facilitating prompt diagnosis and treatment initiation. As hospitals prioritize enhancing emergency care services to meet the needs of a rising patient population, the blood gas and electrolyte analyzers market is witnessing increased adoption of technologically advanced solutions tailored to the urgent and critical care setting.

On the contrary, high costs of analysers hamper the growth of Middle East & Africa blood gas and electrolyte analyzer market.

Based on product, the Middle East & Africa blood gas and electrolyte analyzer market is categorized into blood gas analyzer, electrolyte analyzer, combined analyzer, and others. The combined analyzer segment held 62.5% market share in 2023, amassing US$ 39.62 million. It is projected to garner US$ 48.96 million by 2031 to register 2.7% CAGR during 2023–2031.

By end user, the Middle East & Africa blood gas and electrolyte analyzer market is categorized into hospitals and clinics, clinical and diagnostic laboratories, homecare, and others. The clinical and diagnostic laboratories segment held 72.5% share of Middle East & Africa blood gas and electrolyte analyzer market in 2023, amassing US$ 45.95 million. It is projected to garner US$ 57.36 million by 2031 to expand at 2.8% CAGR from 2023 to 2031.

Based on country, the Middle East & Africa blood gas and electrolyte analyzer market is categorized into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Our regional analysis states that the Rest of Middle East & Africa captured 34.8% share of Middle East & Africa blood gas and electrolyte analyzer market in 2023. It was assessed at US$ 22.06 million in 2023 and is likely to hit US$ 26.20 million by 2031, registering a CAGR of 2.2% during 2023–2031.

Key players operating in the Middle East & Africa blood gas and electrolyte analyzer market are Abbott Laboratories, Dalko Diagnostics Private Limited, Erba Diagnostics Mannheim GmbH, Hoffmann-La Roche Ltd, Medica Corporation, Nova Biomedical Corporation, Siemens Healthineers AG, Werfen SA, Radiometer Medical ApS, and Sensa Core Medical Instrumentation Pvt Ltd., among others.

• In May 2020, Roche launched CE mark availability of Roche v-TAC, a new digital diagnostic solution that allows clinicians to obtain results for arterial blood gas values from patients with respiratory or metabolic abnormalities via a simpler, less invasive venous puncture through the use of a digital algorithm.
• In February 2020, Sensa Core Medical Instrumentation announced the availability of ST-200 CC Blood Gas Analyzer for hospitals, clinics and diagnostic centres through its distributor network all over the world.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com